Overall, these results suggest that the upregulation of CPEB4 was associated with functional resistance of ovarian cancer cells to paclitaxel and is impossibly due to acute inducible effect of paclitaxel in naive sensitive cells. The gene discussed is CPEB4; the disease is ovarian carcinoma.